Aristeia Capital’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-350,000
Closed -$3.51M 880
2021
Q4
$3.51M Hold
350,000
0.06% 320
2021
Q3
$3.5M Hold
350,000
0.07% 286
2021
Q2
$3.52M Hold
350,000
0.07% 280
2021
Q1
$3.45M Buy
+350,000
New +$3.45M 0.07% 299